{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:31:13Z","timestamp":1789637473497,"version":"4.0.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Research Council Starting Grant","award":["639377"],"award-info":[{"award-number":["639377"]}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1T32HL098048 NHLBI"],"award-info":[{"award-number":["1T32HL098048 NHLBI"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PharmaTox Strategic Research Initiative"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Women with unplanned pregnancies use folic acid less frequently, and more often use potentially teratogenic medications in the first trimester. Yet most studies based on routinely collected data lack information on pregnancy planning. Further, only pregnancies proceeding beyond a certain gestational age appear in routinely collected data, creating the possibility for collider-stratification bias. If pregnancy intention could be identified, pregnancies could be ascertained earlier. This study aimed to investigate fertility treatment and discontinuation of oral contraception (OC) as proxies for pregnancy planning by describing variations in patterns of prescription fills for antibiotics and analgesics during the peri-pregnancy period by these proxies of pregnancy intention.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Fertility treatment with clomiphene and discontinuation of OC were identified in the Norwegian Prescription Database (NorPD) and linked with data from the Medical Birth Registry of Norway for the years 2006 to 2017. Filled prescriptions for antibiotics and analgesics from NorPD were displayed for women on fertility treatment, women who discontinued OC before pregnancy, and women who discontinued during pregnancy.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Of 172,585 included pregnancies, fertility treatment was identified in 19,449, and OC discontinuation before or during pregnancy in 153,136. Women who discontinued OC during pregnancy were less likely to use preconception folic acid (25.4%) than women who discontinued before pregnancy (32.9%), and women on fertility treatment (51.0%). Proportions of first trimester prescription fills were 4.9% (analgesics) and 12.8% (antibiotics) for women who discontinued OC during pregnancy, compared to 4.0 and 11.4% in women who discontinued OC before pregnancy, and 4.7 and 11.0% in women on fertility treatment.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>There were no substantial differences in patterns of prescription fills for analgesics and antibiotics before or during pregnancy by fertility treatment and OC discontinuation. This suggests that there were few differences in medication use between women with planned and unplanned pregnancies, or that fertility treatment and timing of OC discontinuation from routinely collected health data cannot stand alone in the identification of unplanned pregnancies. A narrower definition of OC discontinuation during pregnancy seemed to be a better proxy, but this should be confirmed in other studies.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12884-020-03435-4","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T13:03:07Z","timestamp":1606309387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Fertility treatment and oral contraceptive discontinuation for identification of pregnancy planning in routinely collected health data \u2013 an application to analgesic and antibiotic utilisation"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2841-5868","authenticated-orcid":false,"given":"Sarah","family":"Hjorth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mollie","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Tauqeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedvig","family":"Nordeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,25]]},"reference":[{"issue":"4","key":"3435_CR1","doi-asserted-by":"publisher","first-page":"e380","DOI":"10.1016\/S2214-109X(18)30029-9","volume":"6","author":"J Bearak","year":"2018","unstructured":"Bearak J, Popinchalk A, Alkema L, Sedgh G. Global, regional, and subregional trends in unintended pregnancy and its outcomes from 1990 to 2014: estimates from a Bayesian hierarchical model. Lancet Glob Health. 2018;6(4):e380\u20139.","journal-title":"Lancet Glob Health"},{"issue":"2","key":"3435_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/aogs.12816","volume":"95","author":"J Stern","year":"2016","unstructured":"Stern J, Salih Joelsson L, Tyd\u00e9n T, Berglund A, Ekstrand M, Hegaard H, et al. Is pregnancy planning associated with background characteristics and pregnancy-planning behavior? Acta Obstet Gynecol Scand. 2016;95(2):182\u20139.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"3435_CR3","doi-asserted-by":"publisher","first-page":"100869","DOI":"10.1016\/j.pmedr.2019.100869","volume":"14","author":"B Hill","year":"2019","unstructured":"Hill B, Kothe EJ, Currie S, Danby M, Lang AY, Bailey C, et al. A systematic mapping review of the associations between pregnancy intentions and health-related lifestyle behaviours or psychological wellbeing. Prev Med Rep. 2019;14:100869.","journal-title":"Prev Med Rep"},{"issue":"10132","key":"3435_CR4","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/S0140-6736(18)30311-8","volume":"391","author":"J Stephenson","year":"2018","unstructured":"Stephenson J, Heslehurst N, Hall J, Schoenaker DAJM, Hutchinson J, Cade JE, et al. Before the beginning: nutrition and lifestyle in the preconception period and its importance for future health. Lancet. 2018;391(10132):1830\u201341.","journal-title":"Lancet"},{"issue":"4","key":"3435_CR5","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/pds.1906","volume":"19","author":"BJ Cleary","year":"2010","unstructured":"Cleary BJ, Butt H, Strawbridge JD, Gallagher PJ, Fahey T, Murphy DJ. Medication use in early pregnancy-prevalence and determinants of use in a prospective cohort of women. Pharmacoepidemiol Drug Saf. 2010;19(4):408\u201317.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"3435_CR6","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/AOG.0000000000000982","volume":"126","author":"K Palmsten","year":"2015","unstructured":"Palmsten K, Hern\u00e1ndez-D\u00edaz S, Chambers CD, Mogun H, Lai S, Gilmer TP, et al. The Most commonly dispensed prescription medications among pregnant women enrolled in the U.S. Medicaid program. Obstet Gynecol. 2015;126(3):465\u201373.","journal-title":"Obstet Gynecol"},{"issue":"9","key":"3435_CR7","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/pds.4577","volume":"27","author":"A Engeland","year":"2018","unstructured":"Engeland A, Bj\u00f8rge T, Klungs\u00f8yr K, Hjellvik V, Skurtveit S, Furu K. Trends in prescription drug use during pregnancy and postpartum in Norway, 2005 to 2015. Pharmacoepidemiol Drug Saf. 2018;27(9):995\u20131004.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"#cr-split#-3435_CR8.1","doi-asserted-by":"crossref","unstructured":"Ventura M, Maraschini A, D'Aloja P, Kirchmayer U, Lega I, Davoli M, et al. Drug prescribing during pregnancy in a central region of Italy, 2008-2012. BMC Public Health. 2018;18","DOI":"10.1186\/s12889-018-5545-z"},{"key":"#cr-split#-3435_CR8.2","unstructured":"(1) [cited 2019 Aug 20];. Available from: https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-018-5545-z."},{"issue":"1","key":"3435_CR9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/ije\/dyu249","volume":"44","author":"Z Liew","year":"2015","unstructured":"Liew Z, Olsen J, Cui X, Ritz B, Arah OA. Bias from conditioning on live birth in pregnancy cohorts: an illustration based on neurodevelopment in children after prenatal exposure to organic pollutants. Int J Epidemiol. 2015;44(1):345\u201354.","journal-title":"Int J Epidemiol"},{"issue":"10","key":"3435_CR10","first-page":"1899","volume":"25","author":"S Riskin-Mashiah","year":"2012","unstructured":"Riskin-Mashiah S, Auslender R. Periconceptional folic acid and teratogenic drug use in women undergoing fertility treatments. J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2012;25(10):1899\u2013903.","journal-title":"J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet"},{"key":"3435_CR11","volume-title":"Folic acid supplementation in pregnancy","author":"LM Goetzl","year":"2020","unstructured":"Goetzl LM. Folic acid supplementation in pregnancy. 2020 [cited 2020 Jan 14]. Available from: https:\/\/www.uptodate.com\/contents\/folic-acid-supplementation-in-pregnancy."},{"issue":"2","key":"3435_CR12","doi-asserted-by":"publisher","first-page":"e004365","DOI":"10.1136\/bmjopen-2013-004365","volume":"4","author":"A Lupattelli","year":"2014","unstructured":"Lupattelli A, Spigset O, Twigg MJ, Zagorodnikova K, M\u00e5rdby AC, Moretti ME, et al. Medication use in pregnancy: a cross-sectional, multinational web-based study. BMJ Open. 2014;4(2):e004365.","journal-title":"BMJ Open"},{"issue":"8","key":"3435_CR13","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/aogs.12667","volume":"94","author":"AS Ersb\u00f8ll","year":"2015","unstructured":"Ersb\u00f8ll AS, Hedegaard M, Damm P, Johansen M, Tabor A, Hegaard HK. Changes in the pattern of paracetamol use in the periconception period in a Danish cohort. Acta Obstet Gynecol Scand. 2015;94(8):898\u2013903.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"3435_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1742-7843.2009.00494.x","volume":"106","author":"K Furu","year":"2010","unstructured":"Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, S\u00f8rensen HT. The Nordic countries as a cohort for Pharmacoepidemiological research. Basic Clin Pharmacol Toxicol. 2010;106(2):86\u201394.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"3435_CR15","volume-title":"WHOCC - ATC\/DDD Index. WHO Collaborating Centre for Drug Statistics Methodology","author":"WHO","year":"2019","unstructured":"WHO. WHOCC - ATC\/DDD Index. WHO Collaborating Centre for Drug Statistics Methodology. 2019 [cited 2020 Feb 10]. Available from: https:\/\/www.whocc.no\/atc_ddd_index\/."},{"issue":"2","key":"3435_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/aogs.12302","volume":"93","author":"J Langhoff-Roos","year":"2014","unstructured":"Langhoff-Roos J, Krebs L, Klungs\u00f8yr K, Bjarnadottir RI, K\u00e4ll\u00e9n K, Tapper A-M, et al. The Nordic medical birth registers - a potential goldmine for clinical research. Acta Obstet Gynecol Scand. 2014;93(2):132\u20137.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"26","key":"3435_CR17","first-page":"2546","volume":"122","author":"LM Irgens","year":"2002","unstructured":"Irgens LM. Medical birth registry--an essential resource in perinatal medical research. Tidsskr Den Nor Laegeforening Tidsskr Prakt Med Ny Raekke. 2002;122(26):2546\u20139.","journal-title":"Tidsskr Den Nor Laegeforening Tidsskr Prakt Med Ny Raekke"},{"key":"3435_CR18","volume-title":"Veileder i gynekologi. Norsk gynekologisk forening","author":"S Kj\u00f8tr\u00f8d","year":"2015","unstructured":"Kj\u00f8tr\u00f8d S, Hentemann MA, Johansen MS, Hausken J, Veholmen M, Birkeland S. Infertilitet. In: Veileder i gynekologi. Norsk gynekologisk forening; 2015."},{"issue":"4","key":"3435_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/14639230310001621666","volume":"28","author":"E Hemminki","year":"2003","unstructured":"Hemminki E, Klemetti R, Rinta-Paavola M, Martikainen J. Identifying exposures of in vitro fertilization from drug reimbursement files: a case study from Finland. Med Inform Internet Med. 2003;28(4):279\u201389.","journal-title":"Med Inform Internet Med"},{"issue":"1","key":"3435_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.contraception.2015.03.016","volume":"92","author":"JE Triebwasser","year":"2015","unstructured":"Triebwasser JE, Higgins S, Secura GM, Zhao Q, Peipert JF. Pharmacy claims data versus patient self-report to measure contraceptive method continuation. Contraception. 2015;92(1):26\u201330.","journal-title":"Contraception."},{"issue":"2","key":"3435_CR21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/01.ede.0000152914.84962.13","volume":"16","author":"SE Vollset","year":"2005","unstructured":"Vollset SE, Gjessing HK, Tandberg A, R\u00f8nning T, Irgens LM, Baste V, et al. Folate supplementation and twin pregnancies. Epidemiol Camb Mass. 2005;16(2):201\u20135.","journal-title":"Epidemiol Camb Mass"},{"key":"3435_CR22","volume-title":"Legemiddelbruk i svangerskapet og ammeperioden. In: Veileder i f\u00f8dselshjelp","author":"H Nordeng","year":"2020","unstructured":"Nordeng H, Jettestad M, Sitras V. Legemiddelbruk i svangerskapet og ammeperioden. In: Veileder i f\u00f8dselshjelp. Fredrikstad, Hammerfest, Bergen, Oslo: Norsk gynekologisk forening; 2020."},{"issue":"4","key":"3435_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4045\/tidsskr.15.0451","volume":"136","author":"S Nordeng","year":"2016","unstructured":"Nordeng S, Nordeng H, H\u00f8ye S. Bruk av antibiotika i svangerskapet. Tidsskr Den Nor Legeforening. 2016;136(4):317\u201321.","journal-title":"Tidsskr Den Nor Legeforening"},{"issue":"5","key":"3435_CR24","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/AOG.0b013e3182a603bb","volume":"122","author":"BT Bateman","year":"2013","unstructured":"Bateman BT, Mhyre JM, Hernandez-Diaz S, Huybrechts KF, Fischer MA, Creanga AA, et al. Development of a comorbidity index for use in obstetric patients. Obstet Gynecol. 2013;122(5):957\u201365.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"3435_CR25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s40471-017-0104-1","volume":"4","author":"SE Andrade","year":"2017","unstructured":"Andrade SE, B\u00e9rard A, Nordeng HME, Wood ME, van Gelder MMHJ, Toh S. Administrative claims data versus augmented pregnancy data for the study of pharmaceutical treatments in pregnancy. Curr Epidemiol Rep. 2017;4(2):106\u201316.","journal-title":"Curr Epidemiol Rep"},{"issue":"8","key":"3435_CR26","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/pds.3267","volume":"21","author":"PC Koopmans","year":"2012","unstructured":"Koopmans PC, Bos JHJ, de Jong van den Berg LTW. Are antibiotics related to oral combination contraceptive failures in the Netherlands? A case-crossover study. Pharmacoepidemiol Drug Saf. 2012;21(8):865\u201371.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"3435_CR27","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.contraception.2010.08.020","volume":"83","author":"S Toh","year":"2011","unstructured":"Toh S, Mitchell AA, Anderka M, de Jong-van den Berg LTW, Hern\u00e1ndez-D\u00edaz S. National Birth Defects Prevention Study. Antibiotics and oral contraceptive failure - a case-crossover study. Contraception. 2011;83(5):418\u201325.","journal-title":"Contraception."},{"issue":"6","key":"3435_CR28","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1067\/mjd.2002.120448","volume":"46","author":"JSM Archer","year":"2002","unstructured":"Archer JSM, Archer DF. Oral contraceptive efficacy and antibiotic interaction: a myth debunked. J Am Acad Dermatol. 2002;46(6):917\u201323.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"3435_CR29","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/ajcn\/84.5.1134","volume":"84","author":"RM Nilsen","year":"2006","unstructured":"Nilsen RM, Vollset SE, Gjessing HK, Magnus P, Meltzer HM, Haugen M, et al. Patterns and predictors of folic acid supplement use among pregnant women: the Norwegian mother and child cohort study. Am J Clin Nutr. 2006;84(5):1134\u201341.","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"3435_CR30","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jogoh.2019.02.006","volume":"48","author":"D Serfaty","year":"2019","unstructured":"Serfaty D. Update on the contraceptive contraindications. J Gynecol Obstet Hum Reprod. 2019;48(5):297\u2013307.","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"2","key":"3435_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.contraception.2016.04.005","volume":"94","author":"EM Str\u00f8m-Roum","year":"2016","unstructured":"Str\u00f8m-Roum EM, Lid J, Eskild A. Use of contraception among women who request first trimester pregnancy termination in Norway. Contraception. 2016;94(2):181\u20136.","journal-title":"Contraception."},{"issue":"1","key":"3435_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/aogs.13055","volume":"96","author":"I Lindh","year":"2017","unstructured":"Lindh I, Skjeldestad FE, Gemzell-Danielsson K, Heikinheimo O, Hognert H, Milsom I, et al. Contraceptive use in the Nordic countries. Acta Obstet Gynecol Scand. 2017;96(1):19\u201328.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"3435_CR33","volume-title":"Evaluering av bioteknologiloven 2015. Oppdatering om status og utvikling p\u00e5 fagomr\u00e5dene som reguleres av loven","author":"Helsedirektoratet","year":"2015","unstructured":"Helsedirektoratet. Evaluering av bioteknologiloven 2015. Oppdatering om status og utvikling p\u00e5 fagomr\u00e5dene som reguleres av loven. Oslo: Helsedirektoratet; 2015. Aug [cited 2019 Oct 23]. Report No.: IS-2360. Available from: https:\/\/www.helsedirektoratet.no\/tema\/bioteknologi."},{"key":"3435_CR34","volume-title":"40 \u00e5r med assistert befruktning. Tidsskr Den Nor Legeforening","author":"LB Romundstad","year":"2019","unstructured":"Romundstad LB. 40 \u00e5r med assistert befruktning. Tidsskr Den Nor Legeforening. 2019 [cited 2019 Oct 22]; Available from: https:\/\/tidsskriftet.no\/2019\/01\/leder\/40-ar-med-assistert-befruktning."}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-03435-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-020-03435-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-03435-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T13:32:30Z","timestamp":1606311150000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-020-03435-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,25]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3435"],"URL":"https:\/\/doi.org\/10.1186\/s12884-020-03435-4","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,25]]},"assertion":[{"value":"16 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Regional Committee for Research Ethics in South Eastern Norway (approval number 2018\/140\/REK s\u00f8r \u00f8st) and by the Data Protection Officer at the University of Oslo (approval number 58033). The Regional Committee for Research Ethics in South Eastern Norway has granted exemption from the obligation to seek consent from participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"731"}}